Herpes simplex virus virulence: the
functions of the gamma (1)34.5 gene Roizman B,
Markovitz N.
pp. S1-2
Molecular and cellular aspects of
measles virus persistence in the CNS ter Meulen
V.
pp. S3-5
Use of primary CNS
cultures to investigate HIV neurotropism
Gonzalez-Scarano F, Strizki JM, Albright A, Shieh
J pp. S11-3
HIV neuropathogenesis
Levy JA.
pp. S14-5
Neurobiology of Borna disease
virus Lipkin WI, Hatalski CG, Briese T.
pp. S17-20
Neurotoxicity and neuroinvasiveness of
prions Aguzzi A, Raeber A, Blattler T, Flechsig
E, Klein M, Weissmann C, Brandner S.
pp. S23-4
The regulation of gene expression in
neurotrophic viruses Roos RP.
pp.
S25-7
Neuroglial ATF/CREB factors interact
with the human immunodeficiency virus type 1 long terminal
repeat Krebs FC, Goodenow MM, Wigdahl B.
pp. S28-32
Modulation of mouse hepatitis virus
infection by defective-interfering RNA-mediated expression of viral
proteins and cytokines Lai MM, Zhang X, Hinton D,
Stohlman S.
pp. S33-4
Determinants of poliovirus
neurovirulence Gromeier M, Mueller S, Solecki D,
Bossert B, Bernhardt G, Wimmer E.
pp. S35-8
Alzheimer's disease: a dissection of
its etiology Jay G. pp.
S41-2
The role of CD4+ and CD8+ T cells in
demyelinating disease following Theiler's virus infection: a model
for multiple sclerosis Rodriguez M,
Rivera-Quinones C, Murray PD, Kariuki Njenga M, Wettstein PJ, Mak
T.
pp. S43-5
Molecular epidemiology and emerging
infectious diseases of the nervous system Weber
T.
pp. S46-9
Recent studies on the epidemiology,
clinical features and pathogenic mechanisms of HTLV-I associated
myelopathy (HAM/TSP) and other diseases associated to HTLV
Osame M, Nakagawa M, Umehara F, Ijichi S, Moritoyo T,
Higuchi I, Usuku K, Arimura K, Izumo S.
pp. S50-1
Molecular epidemiology of rabies in the
United States: reemergence of a classical neurotropic agent
Rupprecht CE, Smith JS, Krebs JW, Childs JE.
pp. S52-3
A genetic approach to study the
pathogenesis of Theiler's virus persistent infection
Azoulay-Cayla A, Brahic M, Bureau JF, Bihl F, Dethlefs
S, Fiette L, Jarousse N, Larsson-Sciard EL, Martinat C, McAllister
A, Michiels T, Pena Rossi C.
pp. 55
Immune regulation of
coronavirus-induced demyelinating encephalomyelitis
Stohlman SA, Lin M, Parra B, Bergmann CC, Hinton
DR.
pp. S56-7
Signaling pathways in virus-induced CNS
inflammation Dietzschold B, Morimoto K.
pp. S58-9
Epitope spreading leads to
myelin-specific autoimmune responses in SJL mice chronically
infected with Theiler's virus Miller SD,
Vanderlugt CL, Begolka WS, Pao W, Neville KL, Yauch RL, Kim
BS.
pp.S62-5
Lack of correlation of Theiler's virus
binding to cells with infection. McCright IJ,
Fujinami RS.
pp. S68-70
Alternative delivery systems for
antiviral nucleosides and antisense oligonucleotides to the
brain. Levy RM, Ward S, Schalgeter K, Groothuis
D.
pp. S74-5
Viruses and oncogenes in brain
tumors. Archer GE, Sampson JH, Bigner DD.
pp. S76-7
SV40 and human
brain tumors. Butel JS, Lednicky JA, Stewart AR,
Garcea RL, Finegold MJ.
pp. S78-9